NewGenIvf Group Limited (NIVF)
NIVF trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1954
-17.24% on the day
Market cap
$1.7M
Nano cap
Revenue · 2025
$4.7M
-13.0% on 2024
Net income · 2025
$9.9M
209.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NIVF on Nasdaq |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | Singapore |
| IPO year | Not reported by the screener |
| SEC CIK | 0001981662 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | D8 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.7M |
| Net income | $9.9M |
| Operating income | -$10.7M |
| Net margin | 209.0% |
| Operating margin | -226.9% |
| Revenue growth | -13.0% |
| Cash | $759K |
| Total assets | $32.7M |
| P/E (computed) | 0.2× |
| P/S (computed) | 0.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2026-09-30 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-03-31 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-07 |
Source: SEC EDGAR submissions feed, 182 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| NIVFW | NewGenIvf Group Limited Warrants | $0.0121 |
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MGRX | Mangoceuticals Inc. | $0.3716 | -3.08% | $8.3M |
| CCEL | Cryo-Cell International Inc. | $4.30 | -4.44% | $34.7M |
| PARK | Park Dental Partners Inc. | $19.59 | -3.31% | $93.2M |
| VMD | Viemed Healthcare Inc. Common Shares | $9.61 | +0.10% | $366.0M |
| AGL | agilon health inc. | $85.90 | +0.48% | $1.4B |
| PGNY | Progyny Inc. | $27.39 | -2.28% | $2.1B |
| SHC | Sotera Health Company | $18.21 | +0.33% | $5.2B |
| DVA | DaVita Inc. | $182.08 | +0.17% | $11.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier